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Abstract
The World Health Organization (WHO) is currently updating the tenth version of their diag-
nostic tool, the International Classification of Diseases (ICD, WHO, 1992). Changes have
been proposed for the diagnosis of Transsexualism (ICD-10) with regard to terminology,
placement and content. The aim of this study was to gather the opinions of transgender
individuals (and their relatives/partners) and clinicians in the Netherlands, Flanders (Bel-
gium) and the United Kingdom regarding the proposed changes and the clinical applicability
and utility of the ICD-11 criteria of ‘Gender Incongruence of Adolescence and Adulthood’
(GIAA). A total of 628 participants were included in the study: 284 from the Netherlands
(45.2%), 8 from Flanders (Belgium) (1.3%), and 336 (53.5%) from the UK. Most participants
were transgender people (or their partners/relatives) (n = 522), 89 participants were health-
care providers (HCPs) and 17 were both healthcare providers and (partners/relatives of)
transgender people. Participants completed an online survey developed for this study.
Most participants were in favor of the proposed diagnostic term of ‘Gender Incongruence’
and thought that this was an improvement on the ICD-10 diagnostic term of ‘Transsexual-
ism’. Placement in a separate chapter dealing with Sexual- and Gender-related Health or
as a Z-code was preferred by many and only a small number of participants stated that this
diagnosis should be excluded from the ICD-11. In the UK, most transgender participants
thought there should be a diagnosis related to being trans. However, if it were to be
removed from the chapter on “psychiatric disorders”, many transgender respondents indi-
cated that they would prefer it to be removed from the ICD in its entirety. There were no
large differences between the responses of the transgender participants (or their partners
and relatives) and HCPs. HCPs were generally positive about the GIAA diagnosis; most
thought the diagnosis was clearly defined and easy to use in their practice or work. The
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duration of gender incongruence (several months) was seen by many as too short and
required a clearer definition. If the new diagnostic term of GIAA is retained, it should not be
stigmatizing to individuals. Moving this diagnosis away from the mental and behavioral
chapter was generally supported. Access to healthcare was one area where retaining a
diagnosis seemed to be of benefit.
Introduction
TheWorld Health Organization (WHO) is currently updating the tenth edition of their diag-
nostic tool; the International Classification of Diseases (ICD [1]). The ICD is used as a diagnos-
tic tool for epidemiology, health management and clinical purposes and aids the monitoring of
the incidence and prevalence of diseases and other health problems in different countries and
populations. The ICD-11 is scheduled to be released in 2018 [2], making the 26 year period
between both editions without a revision the longest in the ICD’s history.
As part of the development of the new edition of the ICD the diagnostic category of “Gender
Identity Disorders” (F64), which includes Transsexualism (F64.0); Dual-role Transvestism
(F64.1); Gender Identity Disorder of Childhood (F64.2); Other Gender Identity Disorders
(F64.3); and Gender Identity Disorder, Unspecified (F64.4) is being reviewed.WHO’s Working
Group on the Classification of Sexual Disorders and Sexual Health (WGSDSH) was given the
task of “reviewing and evaluating clinical and research data informing gender identity diagno-
ses since the publication of the ICD-10 in 1992” [3]. Based on their review, theWGSDSH
wrote:
“. . .it is now appropriate to abandon the psychopathological model of transgender people
based on 1940s conceptualizations of sexual deviance and to move towards a model that is
(1) more reflective of current scientific evidence and best practices; (2) more responsive to
the needs, experience, and human rights of this vulnerable population; and (3) more sup-
portive of the provision of accessible and high-quality healthcare services”[3].
The revision of the diagnosis related to gender identity was expected to spark debates, as has
been the case when developing the new diagnosis of Gender Dysphoria as part of the fifth edi-
tion of the Diagnostic and Statistical Manual of Mental Disorders (DSM) from the American
Psychiatric Association (APA) (e.g. [3–7]). TheWHO has receivedmany proposals calling for
de-pathologization of a diagnosis of gender identity disorder and its removal from the mental
disorders section of the classification (e.g. from Global Action for Trans Equality–GATE [8]
and the International Campaign Stop Trans Pathologisation [9]). Furthermore, the European
Parliament called on the Commission and theWorld Health Organization to withdraw gender
identity disorders from the mental and behavioral disorders chapter, and to ensure a non-
pathologising reclassification in the negotiations on the ICD-11 [10]. The desire to destigma-
tize gender incongruence and the importance of securing access to care has been described as
the central dilemma in both the DSM-5 and ICD-11 revision processes [3].
TheWGSDSH has proposed to change the name of the diagnosis from Transsexualism/
Gender Identity Disorder to Gender Incongruence and to remove it from the chapter of Mental
and Behavioral Disorders to a new chapter (Conditions Related to Sexual and Gender Health)
[3]. Currently, four diagnoses have been proposed within the diagnostic category of Gender
Incongruence, namely Gender Incongruence of adolescence and adulthood (5A30); Gender
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Incongruence of Childhood (5A31); Other SpecifiedGender Incongruence (5A3Y) and Gender
Incongruence, Unspecified (5A3Z). See [11].
Some of the suggested changes are:
1. Distress or impairment of functioning not to be required for the diagnosis.
2. Gender Incongruence to be present for a shorter period of time: several months as opposed
to two years as per the ICD-10.
3. The wording used to be less binary and therefore the diagnosis to be applicable to a larger
group of individuals. The term “experienced gender” to be used as opposed to “opposite
sex” or “preferred sex” as currently used in the ICD-10. (See S1 Text for the final draft crite-
ria of ‘Gender Incongruence of Adolescence and Adulthood’ of theWGSDSH criteria used
in this study).
In the proposed diagnosis, the person will not be required to experience serious distress or
functional impairment (e.g. inability to function properly in their job or social life) as a conse-
quence of their gender incongruence in order to fulfill the diagnostic criteria. Formerly, people
would only be eligible for the diagnosis, and therefore treatment [3,4], if they experienced seri-
ous distress from their gender incongruence or were unable to function properly because of it.
Since most health insurance systems use a classification code as a requirement to offer health-
care, it is only when a person has a diagnosis that treatment can be provided. The proposed
change entails that people who experience discomfort with their birth assigned gender but who
do not experience significant distress or impaired ability to live a functional life (work, social-
ize, etc.) will now meet the diagnostic criteria and as result, be entitled to access to treatment in
many countries. As a result of these broadened criteria, the diagnosis will be applicable to a
more diverse group of individuals. Although this may result in increased accessibility to health-
care for transgender people wanting treatment, it may also pathologise individuals whomight
not have any problems with their gender incongruence nor desire any treatment. Fulfilling cri-
teria for a diagnosis may be experiencedby some as stigmatizing although theWGSDSH felt,
that by removing it from the mental disorder chapter stigmatization should be reduced [3].
TheWHO encouraged the public to provide feedback on the proposed ICD-11 and made
the proposed criteria available online [11]. Further input is expected through the results of sev-
eral field trials in lower and middle-income countries, funded by theWHO. As a part of this
process and considering that the proposed changes have a number of advantages and disadvan-
tages, the aim of our study was to gather the views of transgender individuals (and their rela-
tives/partners) and clinicians in the Netherlands, Flanders (Belgium) and the United Kingdom
regarding the proposed changes and the applicability and utility of the diagnostic criteria of
Gender Incongruence of Adolescence and Adulthood for clinicians. The opinions regarding the
GIC diagnosis will be reported elsewhere, see [12]. These countries were selected for a number
of reasons. First, the Netherlands, Belgium, and the United Kingdom have established and well
developed gender identity clinic serviceswhich broadly follow similar standards of care
[13,14]. Secondly, they have a different healthcare system as The Netherlands and Flanders
(Belgium) have a health insurance system whereas the United Kingdom has not. The study
also aims to compare the responses between both countries.
Method and Materials
Method
Participants & procedure in the Netherlands and Flanders (Belgium). Participants in
this study consisted of healthcare providers as well as serviceusers of transgender healthcare
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and other stakeholders (i.e., parents of trans children, and siblings or partners of trans people).
Only people over the age of 16 years were included. The following procedure was followed for
the recruitment of healthcare providers: Mental health professionals working in the field of gen-
der incongruencewere recruited from the VUUniversity Medical Center Amsterdam Center of
Expertise on Gender Dysphoria (VUmc-CEGD); the Gender Team of the University Medical
Center Groningen and Transvisie zorg (an organization that provides information, counselling
and psychological care for transgender people and their social environment) in The Nether-
lands; and the Center of Sexology and Gender of the University Hospital in Ghent, Belgium.
Specializedhealthcare providers were sent a link to an online survey to complete. Healthcare
providers who were not specialized in transgender care (e.g., healthcare psychologists, psychia-
trists, general practitioners, general practitioners trainees, social workers) were contacted via e-
mail through the researchers’ networks and were–after agreeing to participate—invited via e-
mail to the online survey. Furthermore, general psychiatrists and psychiatric trainees were
invited to participate in the survey following a research session organized by the Dutch research-
ers. Some people completed the online version, while others completed a pen and paper version
of the survey.
For the recruitment of service users, transgender adults who came to the VUmc- CEGD for
an appointment were invited to participate in the study. If they were interested in participating,
their e-mail address was passed to the researcher and a link to the surveywas sent. Reasons as
to why transgender adults refused to participate were also collected. Parents of children with
gender dysphoria were approached using a mailing list from Dutch a support group for parents
of transgender children. Parents attending the CEGD at the VUmc were also invited to
participate.
A total of 758 people were invited to participate in the Dutch survey (from the Netherlands
and Belgium).Of this group, 36 people refused participation for various reasons (multiple
response options were possible): They did not feel like participating (n = 16); they did not
have time (n = 11); it did not matter to them whether or not the diagnosis (terminology and
criteria) was changed (n = 8); and other reasons (n = 5). Therefore, 722 agreed to participate
and received a link to the survey via e-mail. Despite several reminders, 383 people (53.0%)
failed to open the link to start the survey. At the start of the survey, participants first received
information about the study and were then asked to give written consent by selecting “yes” in
response to the question: “Do you agree to participate in this study?”. Forty-one people gave
consent but did not answer any questions so they were removed from the data set. Another 6
participants were excluded as they answered fewer than 5 questions. A total of 292 Dutch-
speaking participants (284 from the Netherlands, 8 from Belgium) started the survey and
answered at least 5 questions (40.4% of those who received a link to the survey and 38.5% of
all participants who were approached). All participants from Belgiumwere specialized
Healthcare providers. The surveywas not presented to transgender people/or their partners
or relatives in Belgium. The surveywas completed by 223 people (76.4% of included Dutch
participants).
Participants & procedure in the United Kingdom. Information about the study (includ-
ing the service user recruitment procedure) and information sheets were sent by the research
team at the Nottingham Centre for Gender Dysphoria (NCGD) to everyGender Identity
Clinic Service in the UK (n = 8) and the four main surgical centers specialized in trans surgery.
Healthcare professionals working in these clinics were invited to participate, and if they agreed
a link to the online survey was sent. Information regarding reasons for not participating were
recorded. Serviceusers were recruited from the nine Gender Identity Clinic Services, includ-
ing the NCGD. Clinicians provided a brief explanation of the study to the service users and
invited them to participate in the study by providing them with a very brief information sheet
GIAA: Acceptability and Clinical Utility of the Proposed ICD-11 Criteria
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where a link to the survey could be found. Further information about the study and a consent
form were hosted online. A paper copy was offered to potential participants who were not
computer literate, had no access to online facilities, or preferred paper and pen. Only three
individuals requested a paper copy and these were mailed out with a consent form, informa-
tion sheet, and return stamped and addressed envelope; however none were returned. A snow-
ballingmethod was used in order to increase recruitment, with service users sharing the
online link with friends and family, and clinicians with their gender and non-gender specialist
colleagues.
Due to the snowballingmethods used the number of invitations sent is unknown. Overall,
552 UK participants entered the survey. Five people opted to answer the questionnaire regard-
ing non-participation. The reasons given were: no opinion of whether the diagnosis changes
(n = 1); technical issues (n = 1); not feeling knowledgeable enough (n = 1); adverse to the con-
cept of diagnosis (n = 1); and concerns regarding online surveys (n = 1). In total, 387 completed
the survey (70%) and only their responses were saved by the survey software. Seven partici-
pants did not progress past the information page, but all others continued to give consent. Par-
ticipants then dropped out at various stages, the greatest number of drop-outs (n = 71)
occurred for questions regarding the positioning of the diagnosis. Of the 387 participants who
completed the survey, 50 were not from the United Kingdom and were excluded. One other
person was excluded because they were under the age of 16. This resulted in a final UK sample
of 336 participants.
Participants overall. A total of 628 participants were included in data analysis: 284 from
the Netherlands (45.2%); 8 from Flanders (Belgium) (1.3%); and 336 (53.5%) from the UK (see
Table 1 below).
Materials
The research team from the CEGD in Amsterdam developed a questionnaire with the input of
transgender health care professionals and other stakeholders. This questionnaire covered ques-
tions regarding both the Gender Incongruence of Childhoodclassification (GIC) and the Gen-
der Incongruence of Adolescence and Adulthood (GIAA The opinions regarding the GIC
diagnosis will be reported elsewhere, see [12]. The final survey consisted of two parts (see S2
Text for the complete survey). The first part focused on the view of the service users and clini-
cians with regard to the various changes proposed in the new edition of the ICD (as compared
to the ICD-10). The second part was only for healthcare providers and aimed to examine the
clinical utility and the clinical implications of the proposed criteria. A special effort was made
to explain concepts that some participants may have been unfamiliar with through the use of
pop-up information windows that appeared when participants placed their mouse on the blue-
colored, bold and underlinedwords. For example, explanations were provided on the concept
of a Z-code (this concerns “factors that affect health and also influence contacts with the
healthcare system” but does not concern diseases or disorders) and Disorders/Differences of
Sex Development (DSD; when sex development is not completely in the typical male or female
direction).
The Dutch surveywent live on June 2nd 2014 and was open for 10.5 months. The Dutch ver-
sion of the questionnaire was translated into English by a Dutch translation company and then
further amendments to the language were made by the research team in the UK (GW, WB &
CR) to ensure appropriateness and ease of use by lay people. Following this, the questionnaire
was sent to the lead clinicians at all Gender Identity Clinic services in the United Kingdom, as
well as the main providers of gender-related surgery. A meeting took place where stakeholders
could comment on the questionnaire and nomajor amendments were suggested, but the length
GIAA: Acceptability and Clinical Utility of the Proposed ICD-11 Criteria
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of the questionnaire was questioned by various stakeholders. However, changes to this could
not be made for reasons of consistency with the original Dutch version. During the same
period, representatives from the major trans stakeholder groups in the United Kingdom were
invited to meet and discuss the questionnaire in detail. The overarching remit given to this
group was to remain as closely as possible to the original Dutch version of the questionnaire.
Amendments were made to some of the language used, the order of questions, response
options, and a small number of new questions was added. The final version was then translated
back into Dutch by another Dutch translation company and shared with the team in the Neth-
erlands. The online questionnaire went live in the UK on October 1st 2014 and was open for
7.5 months.
The survey began with a series of demographic questions that asked about age, geographical
location, gender identity (identification and description), birth assigned gender, education,
employment status, and respondent category (i.e., trans, relative, healthcare provider). It then
went on to ask about general opinions towards diagnosis and whether the respondent was
Table 1. Frequency Table of Gender Assigned at Birth, Gender Identity, and Level of Education (and Percentages for each Column).
Demographic Respondent Category
All (Relatives/Partners of)
Transgender People
Healthcare providers Both healthcare providers
and (Relatives/Partners of)
Transgender People
Country of data
collection
Country of data
collection
Country of data
collection
Country of data
collection
Total
(n = 628)
NL (n =
292)
UK
(n = 336)
NL
(n = 210)
UK
(n = 312)
Total
(n = 522)
NL
(n = 72)
UK
(n = 17)
Total
(n = 89)
NL
(n = 10)
UK
(n = 7)
Total
(n = 17)
Assigned
gender
Male 334
(53.2%)
123
(42.1%)
211
(62.8%)
103
(49.0%)
195
(62.5%)
298
(57.1%)
17
(23.6%)
13
(76.5%)
30
(33.7%)
3
(30.0%)
3
(42.9%)
6
(35.3%)
Female 292
(46.5%)
169
(57.9%)
123
(36.6%)
107
(51.0%)
115
(36.9%)
222
(42.5%)
55
(76.4%)
4
(23.5%)
59
(66.3%)
7
(70.0%)
4
(57.1%)
11
(64.7%)
Neither 2 (0.3%) 0
(0.0%)
2 (0.6%) 0 (0%) 2 (0.6%) 2 (0.4%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Gender
Identity
Male 187
(29.8%)
104
(35.6%)
83
(24.7%)
81
(38.6%)
67
(21.5%)
148
(28.4%)
17
(23.6%)
13
(76.5%)
30
(33.7%)
6
(60.0%)
3
(42.9%)
9
(52.9%)
Female 346
(55.1%)
163
(55.8%)
183
(54.5%)
105
(50.0%)
177
(56.7%)
282
(54.0%)
55
(76.4%)
4
(23.5%)
59
(66.3%)
3
(30.0%)
2
(28.6%)
5
(29.4%)
Partly
male,
partly
female
27
(4.3%)
10
(3.4%)
17
(5.1%)
9 (4.3%) 17
(5.4%)
26
(5.0%)
0 (0%) 0 (0%) 0 (0%) 1
(10.0%)
0 (0%) 1
(5.9%)
Neither
male nor
female
26
(4.1%)
4
(1.4%)
22
(6.5%)
4 (1.9%) 22
(7.1%)
26
(5.0%)
0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Don’t
know
(yet)
5 (0.8%) 0
(0.0%)
5 (1.5%) 0 (0%) 5 (1.6%) 5 (1.0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Other 37
(5.9%)
11
(3.8%)
26
(7.7%)
11
(5.2%)
24
(7.7%)
35
(6.7%)
0 (0%) 0 (0%) 0 (0%) 0 (0%) 2
(28.6%)
2
(11.8%)
Level of
Education
Low 20
(3.2%)
15
(5.1%)
5 (1.5%) 15
(7.1%)
5 (1.6%) 20
(3.8%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
Middle 251
(40.0%)
110
(37.7%)
141
(42.0%)
109
(51.9%)
141
(45.2%)
250
(47.9%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
1
(10.0%)
0
(0.0%)
1
(5.9%)
High 357
(56.8%)
167
(57.2%)
190
(56.5%)
86
(41.0%)
166
(53.2%)
252
(48.3%)
72
(100%)
17
(100%)
89
(100%)
9
(90.0%)
7
(100%)
16
(94.1%)
doi:10.1371/journal.pone.0160066.t001
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receiving or had received treatment (if applicable). All questions were fixed-choice options, with
spaces provided to answer “other” and add more information if required. The answer options
going through the surveywere a mixture of one-option responses or multi-option responses,
depending upon the question. Options were provided to cover all eventualities, including neu-
tral/no opinion; always with the addition of “other, please specify” or “please explain your
answer” to allow for additional comments. For example, questions that asked for level of agree-
ment would give sevenmain options: “Strongly agree, Agree, agree a little, Neutral; neither
agree nor disagree, Disagree a little, Disagree, and Strongly disagree”, plus “please explain your
answer”. Questions that asked about opinions (e.g., “Do you think. . ..”) would give four main
options: “Yes, No, No opinion, Don’t know” plus “please explain your answer”.
The Dutch study was granted full ethical approval (inclusion of Belgian participants and the
consent method for participants under the age of 18 was covered) by the Commissie
Wetenschappelijk Onderzoek [Committee of Scientific Research] of the EMGO Institute for
Health and Care Research (EMGO+) with project IDWC2014-09 and the UK study was
granted full Ethics Approval (the consent method for participants under the age of 18 was cov-
ered) by the UK National Research Ethics ServiceCommittee East Midlands—Nottingham 1
with IRAS project ID 152591.
Data analysis
Participants who were healthcare provider as well as a transgender person were included in
both the Transgender group (TG) and the Healthcare providers (HCP) group. Differences
between participants from the United Kingdom (UK) and participants from the Netherlands/
Flanders (NL) were explored with a t-test for continuous data (age), Chi-square tests or Fisher’s
Exact test (for the HCP only questions were the sample was smaller and Chi-square assump-
tions were violated) for categorical data and Mann-Whitney U tests for ordinal data or when t-
test assumptions were violated. As participants who were both HCP and TG persons were
included in both groups, the TG and HCP group were not independent. Therefore, no statisti-
cal differences between these groups were explored. The results of the HCP group are described
after the TG group.
Results
Sample Characteristics
Based on the respondent type categories selected (see S3 Text for the additional information on
respondent categories), participants were divided into three categories: healthcare providers
(HCP), service users (transgender persons and their partners and/or relatives) (TG) and partic-
ipants who are both healthcare providers and (partners/relatives of) transgender persons
(Both). The TG group consists mainly of transgender persons (see Table A in S3 Text), but also
parents of children/adolescentswith gender incongruent feelings were included, as they have
first-hand experiencewith the healthcare provided for their child. Furthermore, some partners
and relatives of transgender persons were included in the TG group. The vast majority of all
participants were service users (or their partners/relatives) (n = 522), 89 participants were
healthcare providers and 17 participants were both healthcare providers and (partners/relatives
of) transgender people, see Table 1. These three categories were used to analyse the responses
on the survey questions.
The age of the participants ranged between 16 and 78 with a mean of 38.72 (SD = 14.59).
There was no statistical difference between the mean age in the Netherlands (M = 38.47,
SD = 13.64, n = 290) and the UK (M = 38.94, SD = 15.38, n = 336), t(624) = -.40, p = .69. The
level of education did not differ between the Netherlands and the UK (U = 48589.5, p = .81).
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For sociodemographic characteristics on assigned gender, gender identity and level of educa-
tion see Table 1.
For each question, the results of the transgender participants are described first, followed by
the findings from the healthcare providers. Finally, the findings from the specific questions for
healthcare providers are presented. Transgender participants who are healthcare providers are
included in both the Transgender group and the Healthcare providers (HCP) group.
General Features of the Diagnosis
Terminology. Respondents were asked what they thought of the statement that the ICD-
10 diagnostic term of transsexualism should change on a seven point scale (from strongly agree
to strongly disagree). In the TG group (n = 532), the mean agreement was 2.45 (SD = 1.62).
When comparing the responses between the two countries a statistical difference was found
(U = 28586, z = -3.23, p = .001, r = -.14). The UK TG participants scored lower (M = 2.32,
SD = 1.65, n = 319, mean rank = 249.61) than the NL TG participants (M = 2.64, SD = 1.55,
n = 213, mean rank = 291.79), indicating that the UK participants agreed stronger with the
statement than the NL participants.When the possible responses were grouped into three cate-
gories (agree to various degrees, neutral, disagree to various degrees), it was found of the UK
TG participants, 78.7% (n = 251) agreed with the statement compared to 67.6% (n = 144) of
the NL TG participants. Of the NL participants, 22.5% (n = 48) reported being neutral com-
pared to 11.6% (n = 37) of the UK participants. In NL 9.9% (n = 21) and in the UK 9.7%
(n = 31) disagreedwith the statement. Like the TG participants, the majority of HCPs (88.7%;
n = 94) agreed (to various degrees) with the statement that the ICD-10 diagnostic term of
transsexualism should change.
In the UK, most transgender participants considered the term gender incongruence to be an
improvement on transsexualism (68.7%; n = 219). Most UKHCP also saw this as an improve-
ment (83.3%, n = 20). Furthermore, gender incongruence was selectedmost frequently (22.2%;
n = 70) as the preferred diagnostic term in the UK. Other frequently selected terms were: gen-
der dysphoria (19.4%; n = 61), gender variance (13.3%; n = 42), gender diversity (11.7%; n = 37),
or another term (12.1%; n = 38) (see Table 2). Examples of other terms include: “Sex-based
Table 2. Frequency Table (and Percentage of Column) of Responses to the Question (UK only): Do you consider the proposed name of gender
incongruence an improvement on transsexualism?; and preferences for Diagnostic term.
Question Possible answer N and percentage
response
Do you consider the proposed name of gender incongruence an improvement on transsexualism?
(n = 319)
No 59 (18.5%)
Yes 219 (68.7%)
Doesn’t matter 34 (10.7%)
No opinion 7 (2.2%)
Preferences for Diagnostic Term (n = 315) Gender transition 15 (4.8%)
Gender diversity 37 (11.7%)
Gender variance 42 (13.3%)
Gender incongruence 70 (22.2%)
Gender dysphoria 61 (19.4%)
Trans 24 (7.6%)
Transsexuality 12 (3.8%)
Gender identity
disorder
16 (5.1%)
Other, please specify 38 (12.1%)
doi:10.1371/journal.pone.0160066.t002
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Dysphoria/ Dysmorphia”; “Misgendered at Birth”; “Gender fluidity”; “Transgender” and “Gen-
der Condition”. Rather than writing down a term, some participants gave statements, for exam-
ple: “Trans people should not be pathologised through medical diagnoses.” or “Culturally
Induced Gender Anxiety Disorder”—caused by an inability to express our true selves due to
social expectations, gender stereotypes, or situational constraints.” In line with the UK TG
respondents, most UK HCPs (54.2%, n = 13) preferred gender incongruence as a diagnostic
term. Other terms selectedwere gender diversity (16.7%, n = 4), gender variance (12.5%, n = 3),
gender dysphoria (12.5%, n = 3), or another term (4.2%, n = 1).
The Dutch surveywas less specific in asking about the preferred diagnostic term. Dutch par-
ticipants were asked their opinion regarding the following statement: “Do you consider the
proposed name of gender incongruence an improvement on transsexualism or gender identity
disorder?”Most transgender participants (and their family and/or partner) (58.0%; n = 120)
responded with “yes” to this statement, 23.7% (n = 49) said ‘no’, 14.5% (n = 30) said “doesn’t
matter” and 3.9% (n = 8) had no opinion. Most Dutch HCPs (79.7%, n = 63) also noted they
saw Gender Incongruence as an improvement.
Positioning of the Diagnosis
Respondents were asked what they thought of the statement that gender incongruence among
adolescents/adults is a psychiatric disorder on a seven point scale (from strongly agree to
strongly disagree). In the TG group (n = 524), the mean agreement was 5.73 (SD = 1.66). There
were no differences between the countries,U = 35395.5, z = 1.70, p = .09, r = .07: the mean
score of the UK TG participants (n = 319) was 5.85 (SD = 1.56, mean rank = 270.96) and 5.54
(SD = 1.79, mean rank = 249.34) of the NL TG participants (n = 205). When the possible
responses were grouped into three categories (agree to various degrees, neutral, disagree to var-
ious degrees), it was found that 77.3% of the TG respondents (n = 405) disagreed (to various
degrees) with the statement that “Gender incongruence in adolescents/adults is a psychiatric
disorder”, 11.1% (n = 58) were neutral, and 11.6% (n = 61) agreed (to various degrees) with the
statement. In line with the results of the transgender participants, the majority of the HCPs
(57.3%; n = 59) disagreed (to various degrees) with the statement that gender incongruence
among adolescents/adults is a psychiatric disorder, while 22.3% (n = 23) was neutral and 20.4%
(n = 21) agreed.
When people were asked in which chapter they thought a diagnosis of gender incongruence
for adolescents/adults should be included, a large majority of TG participants thought the diag-
nosis should be included somewhere in the ICD-11. However, 7.2% (n = 36) said that the diag-
nosis should not be in the ICD at all (see Table 3). Participants most frequently (38.1%;
n = 191) reported thinking the gender incongruence diagnosis should be placed in a separate
chapter dealing with symptoms and/or disorders regarding sexual- and gender-related health.
The secondmost selected option was to include gender incongruence as a Z-code (26.5%;
n = 133). There were statistical differences between the countries (χ2(8) = 38.54, p< .01, Cra-
mer’s V = .28). In the UK, the most frequently selected option was to include a gender incon-
gruence diagnosis as a Z-code (32.6%; n = 104) and the secondmost preferred option was a
separate chapter dealing with symptoms and/or disorders regarding sexual and gender health
(30.7%; n = 98). In contrast, most NL participants preferred gender incongruence to be placed
in a separate chapter dealing with symptoms and/or disorders regarding sexual and gender
health (51.1%; n = 93) and their next preferred placement was as a Z-code (15.9%; n = 29).
Overall 49 HCPs (49.0%) thought the gender incongruencediagnosis should be placed in a sep-
arate chapter dealing with symptoms and/or disorders regarding sexual and gender health. The
secondmost reported option was to include GIAA as a Z-code (21.0%; n = 21). Only 3 (3%)
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HCPs (1 from NL, 2 from the UK) thought gender incongruence should not be in the ICD at
all. In line with the results of the Dutch TG participants, Dutch HCPs preferred the GIAA to be
placed in a separated chapter (52.6%; n = 40) and the next preferred placement was as a Z-code
(15.8%; n = 12). Similarly, in line with the UK TG paricipants, the most frequently selected
placement options by UKHCPs was as a separate chapter (37.5%; n = 9) or as a Z-code (37.5%;
n = 9).
The UK transgender participants (n = 319) were asked the three following questions (not
present in the Dutch version). The first was: “Do you feel that there should be a diagnosis
related to being trans?” The majority (74.9%; n = 239) answered affirmatively; 18.2% (n = 58)
felt there should not be a diagnosis related to being trans; and 6.9% (n = 22) had no opinion.
The majority of UK HCPs (91.7%; n = 22) thought there should be a diagnosis.
The second question was: “Do you think having a psychiatric diagnosis for gender incon-
gruence (gender dysphoria/gender identity disorder) could have a beneficial effect for adults
and adolescents?”Most UK participants (67.7%; n = 216) thought that having a psychiatric
diagnosis of GI could have beneficial effects for adolescents/adults; 16.0% (n = 51) thought
that it would not; 5.3% (n = 17) had no opinion; and 11.0% (n = 35) responded with ‘other,
please specify’. Similar results were found from the UK HCPs: Most thought there were bene-
fits (70.8%; n = 17); 25.0% (n = 6) did not; and 4.2% (n = 1) had no opinion.
Furthermore, UK participants were asked: “How would you respond if the adolescent/
adult diagnosis for gender incongruencewere to be taken out of the chapter on Psychiatric
disorders?” UK TG participants most frequently reported that a diagnosis of GI should be
removed from the ICD in its entirety (47.0%; n = 150); 35.1% (n = 112) thought the diagnosis
of GI should be allowed to remain in the ICD; 16.9% (n = 54) had no opinion; and 0.9%
(n = 3) said it did not matter. The UK HCPs were split with 45.8% (n = 11) who thought the
diagnoses should be retained and 41.7% (n = 10) who thought the diagnosis should be
removed. The rest had no opinion (8.3%; n = 2) or said it did not matter (4.2%; n = 1).
Stigmatization due to a Diagnosis
In the NL survey only, the following question was asked: “Do you consider that having a psy-
chiatric diagnosis (including diagnoses other than gender incongruence) has a stigmatizing
effect?” The majority of the participants responded with ‘yes’ (77.8%; n = 151); although 9.8%
(n = 19) of respondents said ‘no’. The remaining participants had no opinion (9.3%; n = 18); or
gave another response (3.1%; n = 6).
Table 3. Frequency Table (and Percentage of Column) of Opinions Regarding the Statement: In what chapter of the ICD-11 do you think the diag-
nosis of gender incongruence for adolescents/adults should be included?
Chapter Country of data collection
NL (n = 182) UK (n = 319) Total (n = 501)
Neurologic disorders and diseases 8 (4.4%) 14 (4.4%) 22 (4.4%)
Hormonal disorders and diseases 10 (5.5%) 19 (6.0%) 29 (5.8%)
Urogenital disorders and diseases 0 (0.0%) 3 (0.9%) 3 (0.6%)
Psychiatric disorders and diseases 8 (4.4%) 4 (1.3%) 12 (2.4%)
It should be part of several medical chapters simultaneously 11 (6.0%) 40 (12.5%) 51 (10.2%)
A separate chapter dealing with symptoms / disorders regarding sexual and gender health 93 (51.1%) 98 (30.7%) 191 (38.1%)
It should be a Z-code 29 (15.9%) 104 (32.6%) 133 (26.5%)
It should not be in the ICD at all 11 (6.0%) 25 (7.8%) 36 (7.2%)
Other 12 (6.6%) 12 (3.8%) 24 (4.8%)
doi:10.1371/journal.pone.0160066.t003
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In both countries the following question was asked: “Do you consider that having a diagno-
sis for gender incongruence specifically had a stigmatising effect for adults and adolescents?”
Looking at the responses of the Dutch speaking population only—in order to make comparison
with the above question—42.3% (n = 82) of the respondents answered affirmatively; 25.8%
(n = 50) said ‘no’; 21.1% (n = 41) had no opinion; and 10.8% (n = 21) gave another response.
This indicates that in the Netherlands and Flanders (Belgium) less participants considered the
diagnosis for gender incongruence to be stigmatizing when compared to a psychiatric diagno-
sis. The question about the gender incongruence diagnosis, did not specify in which chapter
that diagnosis would be placed in.
When looking at the TG responses to the above question in both countries, most partici-
pants (60.8%; n = 312) considered that having a diagnosis for gender incongruence had a stig-
matizing effect for adults and adolescents. The study found a statistical difference between the
countries regarding this question (χ2(3) = 57.82, p< .001, Cramer’s V = .34). In NL 42.3%, and
in the UK 72.1%, considered a diagnosis for gender incongruence to have a stigmatizing effect.
Similar results were found for HCPs; most (62.4%) thought a GI diagnosis was stigmatizing for
adults and adolescents (see Table 4 below).
When asked if they thought that having any psychiatric disorder affords recognition, 46.9%
of the participants agreed although 22.2% of the participants disagreed.UK participants dif-
fered fromNL participants (χ2(3) = 55.88, p< .001, Cramer’s V = .33). In the Netherlands
Table 4. Frequency Table (and Percentage of Column) Regarding Statements About the Stigmatising Effect and/or Recognition as a Result of
Having a (Gender Incongruence) Diagnosis.
Question Possible
answer
Country of data
collection
NL UK Total
Do you think having a diagnosis for gender incongruence has a stigmatising effect for adults and
adolescents?
No 50 (25.8%) 38 (11.9%) 88 (17.2%)
Yes 82 (42.3%) 230
(72.1%)
312
(60.8%)
No opinion 41 (21.1%) 17 (5.3%) 58 (11.3%)
Other 21 (10.8%) 34 (10.7%) 55 (10.7%)
n = 194 n = 319 n = 513
Do you think having any kind of psychiatric diagnosis (includingdiagnoses other than gender
diagnoses) affords recognition?a
No 13 (7.0%) 99 (31.0%) 112
(22.2%)
Yes 120
(64.5%)
117
(36.7%)
237
(46.9%)
No opinion 40 (21.5%) 58 (18.2%) 98 (19.4%)
Other 13 (7.0%) 45 (14.1%) 58 (11.5%)
n = 186 n = 319 n = 505
Do you think having a diagnosis for gender incongruence affords recognition? b No 13 (7.0%) 79 (24.8%) 92 (18.2%)
Yes 129
(69.4%)
165
(51.7%)
294
(58.2%)
No opinion 21 (11.3%) 37 (11.6%) 58 (11.5%)
Other 23 (12.4%) 38 (11.9%) 61 (12.1%)
n = 186 n = 319 n = 505
a The wording for this question in the UK differed slightly: “Do you think having any kind psychiatric diagnosis (including diagnoses other than gender
diagnoses) affords validation of your identity, practice or issues?”
b The wording for this question in the UK differed slightly: “Do you think having a diagnosis for gender incongruence (gender dysphoria/gender identity
disorder) affords validation of your identity, practice or issues?”
doi:10.1371/journal.pone.0160066.t004
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64.5% thought any psychiatric diagnosis could afford recognition, compared to only 36.7% in
the UK. In the UK, 31.0%, and in the NL sample 7.0%, thought a psychiatric diagnosis could
not afford recognition.However, the wording of the question differed between the countries.
In the Netherlands the question was: “Do you think any kind of psychiatric diagnosis (includ-
ing diagnosis other than gender diagnoses) affords recognition” and in the UK: “Do you think
having any kind psychiatric diagnosis (including diagnoses other than gender diagnoses)
affords validation of your identity, practice or issues?” The differences found in responses
might be caused by the different wording and interpretation of the questions.
When asked specifically if a gender identity diagnosis could afford recognition (similar to
the previous question, the wording differed between the NL and UK), the majority of the
respondents (58.2%) agreed but 18.2% of the respondents disagreed. Again, the survey found
differences between the UK and the Netherlands (χ2(3) = 26.68, p< .001, Cramer’s V = .23).
Of the Dutch participants, 69.4% agreed with the statement that a GI diagnosis can afford rec-
ognition whereas in the UK, 51.7% of participants did. UK participants (24.8%) disagreed
more frequently than Dutch participants (7.0%) (see Table 4). Similar results were found for
HCPs: most (71.7%) thought a GI diagnosis affords recognition.
In summary, most participants considered having a diagnosis for gender incongruence to be
stigmatizing for adults and adolescents. Compared to the Dutch participants, UK participants
were more concerned about the stigmatization of this diagnosis and were less inclined to think
that a GI diagnosis could afford recognition.
Experiences with Discrimination
The majority of TG respondents (60.4%; n = 93 in NL and 84.6%; n = 252 in UK) reported hav-
ing experienceddiscrimination.When participants were asked to provide examples of discrim-
ination, some of the replies were “Most days, at least something” (UK participant) or “Too
much to mention. I could write a thick book about it” (Dutch participant).
In specific reports of discrimination, participants mentioned occupational discrimination—
some reported losing their employment after starting their transition and others reported not
receiving a promotion that they felt was justified. For example, a Dutch participant reported: “I
was rejected for a promotion at work, because this would be a ‘difficult situation for others’.”
Some participants reported examples of educational discrimination, for example, as one UK
participant noted: “I was refused a place on a college course because it would 'be too much
work'.”
Other participants reported running into difficultiesdue to the legal gender documentation
that did not match their gender identity and/or presentation; as one Dutch participant
reported: “That my ID card still said I was male, while I didn’t look like one. Once I was removed
from a train by a conductor, because I couldn’t prove my identity; mister conductor didn’t believe
that it was me on my ID-card. But this problem is solved with the new law.” A few participants
(in both countries) also reported having been the victim of street-harassment, and/or (sexual)
violence. For example, a UK participant reported: “I have been beaten, spat on, attacked with a
knife, sexually assaulted, refused access to premises such as shops and gyms.”
Participants reported having experienceddiscrimination for several reasons (see Table 5).
There was a statistical difference between the levels of discrimination reported between coun-
tries. In the Dutch speaking countries, 39.6% of participants reported never having been dis-
criminated against, while this was only reported by 15.4% of the UK participants (χ2(1) =
32.84, p< .001, Cramer’s V = .27).
While many UK participants reported experiencing discrimination, the majority of them
(68.5%; n = 198) also reported having experienced/experiencingbenefits or positives from
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being a trans person. Examples of benefits or positives include: “Being able to express myself as
me, rather than having to stick to gender roles imposed by family/society” and “Greater knowl-
edge and understanding about social justice issues, particularly sexism. Strong companionships
with other trans people. A deepened relationship with God.” However 31.5% (n = 91) reported
not having experienced/ experiencing any benefits or positives and some of the explanations
provided by respondents in this group include: “Stigma. It's tough to be visibly trans” and “All it
does is make life much harder”.
Widening the scope of the diagnosis
To find out what participants thought about the broadened diagnostic criteria, the survey
asked whether they would consider it an improvement if the scope of the diagnosis was wid-
ened. See Table 6 for the responses selected by participants in the UK and NL. The most
selected response in both countries was: “”Yes, treatment will thus become available to a more
Table 6. Number of Times a Response was given (and Percentage of Participants that Selected the
Response Option) in the Dutch (NL) and United Kingdom (UK) Survey Regarding the Statement:
‘Would You Consider it an Improvement if the Scope of the Diagnosis were Widened?’
Possible responsea Country of response
NL
(n = 182)
UK
(n = 317)
Total
No, the risk is too high that people will get the diagnosis even though they
don’t need any help: I think it’s stigmatising.
9 (4.9%) 20 (6.3%) 29
Yes, but there is a danger that too many people will get the diagnosis;
even those who do not need it. That is stigmatising.
62 (34.1%) 49 (15.5%) 111
Yes, treatment will thus become available to a more diverse and larger
group.
99 (54.4%) 174
(54.9%)
273
No opinion 18 (9.9%) 23 (7.3%) 41
Other (NL only) 18 (9.9%) - -
No, because (UK only) - 17 (5.4%) -
Yes, because (UK only) - 35 (11.0%) -
a The percentages indicate the proportion of respondents who selected that reason. Selecting multiple
reasons was possible, therefore the sum of the percentages is over 100%.
doi:10.1371/journal.pone.0160066.t006
Table 5. Number of Times a Reason was Ticked (and Percentage of Participants that Selected the Reason) in the Dutch (NL) and United Kingdom
(UK) Survey in Response to the Question:: “Have You Ever Been Discriminated Against for any of the Following Reasons:”.
Possible reasonsa Country of data collection
NL(n = 154) UK(n = 298) Total(n = 452)
Gender variant behaviour 54 (35.1%) 170 (57.0%) 224 (49.6%)
Gender dysphoric feelings 36 (23.4%) 140 (47.0%) 176 (38.9%)
The way in which you express your gender identity by your dress or hair style (your gender expression) 70 (45.5%) 197 (66.1%) 267 (59.1%)
Your gender diagnosis 19 (12.3%) 84 (28.2%) 103 (22.8%)
Other reason 15 (9.7%) 5 (1.7%) 20 (4.4%)
I have never been discriminated against 61 (39.6%) 46 (15.4%) 107 (23.7%)
a The percentages indicate the proportion of respondents who selected that reason. Selecting multiple reasons was possible, therefore the sum of the
percentages is over 100%.
doi:10.1371/journal.pone.0160066.t005
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diverse and larger group”, see Table 6. Since the response options differed across the countries,
direct comparisons between countries cannot be made.
Regarding the widening of the diagnosis, two options were given: 1) the risk of too many
people getting a diagnosis, and 2) the risk of too few people getting a diagnosis.When asked to
indicate which of the two risks they would choose if they had to, the survey found that most
participants preferred the first option (71.4%; n = 130 in NL; 60.5%; n = 193 in UK). In the NL
28.6% (n = 52) and in the UK 16.9% (n = 54) of participants selected the second option. In the
UK survey, an extra response option was included: “I don’t know”. This response was selected
by 22.6% (n = 72) of UK participants. Since the response options differed across the countries,
direct comparisons between countries cannot be made. In line with the findings of the TG par-
ticipants, just over half the Dutch HCPs also preferred the risk of too many people getting a
diagnosis over the risk over too few people getting a diagnosis (63.5%; n = 47). UK HCPs, on
the other hand, selected option 2 most frequently (45.8%, n = 11), followed by option 1 (29.2%;
n = 7).
One of the possible effects of the widening of the diagnosis is that more individuals may
apply for treatment, including people with non-binary gender identities.When asked: “Do you
think that, if the scope of the diagnosis is widened,more people who do not experience them-
selves to be either men or women; or who experience themselves to be outside the boxes of
manhood or womanhood, etc., will seek care or treatment?”, participants responded with: “I
think so, but I'm not sure” (45.7%), followed by “Definitely” (26.9%), see Table 7. Responses
differed between the countries (χ2(3) = 28.28, p< .001, Cramer’s V = .24) with the UK being
more sure this group would seek treatment in such circumstances than the Netherlands (see
Table 7).
Leaving out the Criterion of Distress and Impairment
When asked if participants thought it was an improvement that the criterion of distress was no
longer required, participants in both countries most frequently (59.9% in NL and 48.6% in
UK) selected the response option: “Yes, because, this way, people who do not experience distress
from their gender incongruence but who do wish to receive treatment will be able to get a diag-
nosis and become eligible for treatment,” see Table 8 for all responses.
Healthcare Funding
Less than half of the participants (42.8%; n = 214) expected that there will be changes in health-
care funding for a gender diagnosis if the diagnosis changes; however 34.4% (n = 172) of the
respondents had no opinion regarding this; and 22.8% (n = 114) of the respondents did not
think there would be changes in healthcare funding. There was a statistical difference between
the responses between the countries (χ2(2) = 23.58, p< .001, Cramer’s V = .22): 26.6% of UK
Table 7. Responses to the Question: “Do You Think That, if the Scope of the Diagnosis is Widened, More People Who Do Not Experience Them-
selves to be Either Men or Women; or Who Experience Themselves to be Outside the Boxes of Manhood or Womanhood, etc., Will Seek Care or
Treatment?”
Possible response Country of response Total (n = 501)
NL (n = 182) UK (n = 319)
I don’t know 28 (15.4%) 45 (14.1%) 73 (14.6%)
I don’t think so 35 (19.2%) 29 (9.1%) 64 (12.8%)
I think so, but I’m not sure 93 (51.1%) 136 (42.6%) 229 (45.7%)
Definitely 26 (14.3%) 109 (34.2%) 135 (26.9%)
doi:10.1371/journal.pone.0160066.t007
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participants (n = 85) and 48.1% of Dutch participants (n = 87) did not have an opinion; 33.1%
of the Dutch participants (n = 60) and 48.3% of UK participants (n = 154) expected that the
healthcare funding will change; and 18.8% of Dutch participants (n = 34) and 25.1% of UK par-
ticipants (n = 80) did not expect that healthcare funding would change. Similar results were
found for HCPs: around half of the participants (51.0%; n = 50) expected that healthcare fund-
ing will change if the diagnosis changes.
Duration of Gender Incongruence
In the proposed diagnosis for adolescents and adults, it will be a requirement for gender incon-
gruence to have lasted for a few months. This is to prevent people with highly fluctuating or
very recent gender incongruence from getting a premature diagnosis and potentially starting
irreversible treatments. In the previous ICD version, a period of two years was applied. Around
half of the participants (55.1% in the NL and 48.6% in the UK) thought that the proposed dura-
tion of a fewmonths was too short. A small percentage (4.5% in the NL and 13.2% in UK)
thought that a fewmonths was still too long (see Table 9). There was a statistically significant
difference between the countries (χ2(3) = 10.70, p = .01, Cramer’s V = .15). In line with the
transgender respondents, most HCPs (79.8%; n = 75) thought the proposed duration of gender
incongruencewas too short.
Table 8. Number of Times a Response was given (and Percentage of Participants that Selected the Response Option) in the Dutch (NL) and
United Kingdom (UK) Survey Regarding the Statement: ‘In the ICD-11 it is Not Necessary to Experience Significant Distress that Impairs Their
Ability to Live a Functional Life. Do You Think That Would be an Improvement?’.
Possible responsea Country of response Total
NL
(n = 177)
UK
(n = 319)
No, because, this way, the diagnosis will also apply to people who experience gender incongruence but don’t have a
problem with it. This stigmatises a large group of people.
25 (14.1%) 16 (5.0%) 41
No, because, without experiencing distress, a person should not be able to get a diagnosis. 16 (9.0%) 31 (9.7%) 47
Yes, because, this way, people who do not experience distress from their gender incongruence but who do wish to
receive treatment will be able to get a diagnosis and become eligible for treatment.
106
(59.9%)
155
(48.6%)
261
Yes, because leaving out the criterion of psychological distress means that the diagnosis can be taken out of the
psychiatric chapter.
48 (27.1%) 61 (19.1%) 109
No opinion 16 (9.0%) 8 (2.5%) 24
Doesn’t matter 1 (0.5%) 1 (0.3%) 2
Other 25 (14.1%) 11 (3.4%) 36
No because (UK Only) - 8 (2.5%) -
Yes because (UK only) - 28 (8.8%) -
a The percentages indicate the proportion of respondents who selected that reason. In the Dutch sample, selecting multiple responses was possible
(therefore the sum of the percentages is over 100%), in the UK sample it was not.
doi:10.1371/journal.pone.0160066.t008
Table 9. Frequency Table (and Percentage of Column) of Responses to the Question: How do You Feel About Limiting the Duration of Gender
Incongruence to a Few Months?
Country of response
Possible response NL(n = 176) UK(n = 319) Total(n = 495)
Too short 97 (55.1%) 155 (48.6%) 252 (50.9%)
Still too long 8 (4.5%) 42 (13.2%) 50 (10.1%)
No opinion 25 (14.2%) 53 (16.6%) 78 (15.8%)
Other 46 (26.1%) 69 (21.6%) 115 (23.2%)
doi:10.1371/journal.pone.0160066.t009
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The UK survey asked TG participants what they thought was an appropriate time period.
There were four possible options: 0–6 months, minimum of 1 year, minimum of 2 years, or 5
+ years. Up to 6 months (n = 139; 43.6%) and a minimum of 1 year (n = 139; 43.6%) were the
most frequently chosen options by participants. A total of 36 respondents selected a minimum
of 2 years (11.3%) and only 5 selected 5+ years (1.6%). Of the UKHCPs, 16 (66.7%) selected a
period of a minimum of a year, 5 (20.8%) selected a minimum of 2 years, 2 (8.3%) selected 0–6
months, and 1 (4.2%) selected 5+ years.
Disorders/Differences of Sex Development (DSD)-Specification
Most participants in both countries (75.6% in the NL, 90.3% in the UK) thought that individu-
als with DSD should be able to receive a GI diagnosis. However, in NL 6.8% (n = 12) and in the
UK 0.9% (n = 3) of the participants thought individuals with DSD should not be able to receive
a GI diagnosis. Since the response options differed across the countries (in the UK there was a
“Other”-option that was not present in the Dutch survey), direct comparisons between coun-
tries cannot be made. Similarly, most HCPs (71.0%) thought that individuals with DSD should
be able to receive a GI diagnosis.
Results from the Healthcare Provider Only Questions
Healthcare providers received questions with regard to the consequences of the changes in the
criteria for their clinical practice/workwhich were not of direct relevance to trans people and
their family/partners who therefore did not receive this set of questions.
Widening the scope of the diagnosis. Healthcare providers were asked if they already met
with clients/patients in their work to whom the wider scope of diagnosis might apply (for
instance, a person who does not feel to be either man or woman, and who wishes to live their
live as a gender-neutral person). Half of the HCPs responded with “yes, sometimes” (n = 45;
51.1%). The responses differed between the countries (Fisher’s Exact Test was significant,
p< .01). Furthermore, the responses differed betweenHCPs specialized in transgender care
and non-specializedHCPs (Fisher’s Exact Test was significant, p< .001). See Table 10 for a
summary of the results.
Clarity and applicability of the diagnosis. The majority of healthcare providers (86.7%;
n = 65) thought the diagnostic criteria were defined clearly; five people (6.7%) thought that the
GIAA diagnosis was unclear and five (6.7%) had no opinion. Of these five health care providers
(4 specialized, 1 not specialized; 4 from the UK, and 1 from NL)—one thought the wording
was too general, one thought the wording was too specific, one had no opinion, and two felt
something else about the criteria. One HCP wrote: “the time limit is random” and another
wrote: “Trying to fit several people into one name. It should be some categories”.
Table 10. Frequency Table (and Percentage of Column) Regarding the Question (only for Healthcare Providers): ‘Have you Already Met with Cli-
ents/Patients in your Work to Whom This Wider Scope of Diagnosis Might Apply (for Instance, a Person Who Does not Feel Themselves to be
Either Man or Woman, and Wish to Live Their Live as gender-Neutral, Non-Binary Persons)?’
Possible response Total(n = 88) Country of response Specialization
NL(n = 68) UK(n = 20) Specialized(n = 51) Not Specialized(n = 37)
No, never 23 (26.1%) 23 (33.8%) 0 (0.0%) 5 (9.8%) 18 (48.6%)
Yes, sometimes 45 (51.1%) 29 (42.6%) 16 (80.0%) 29 (56.9%) 16 (43.2%)
Yes, regularly 16 (18.2%) 12 (17.6%) 4 (20.0%) 15 (29.4%) 1 (2.7%)
Other 4 (4.5%) 4 (5.9%) 0 (0.0%) 2 (3.9%) 2 (5.4%)
doi:10.1371/journal.pone.0160066.t010
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Most HCPs (70.7%; n = 53) thought that the criteria for adolescents/adults would be easy to
use in their clinical practice/work; 5.3% (n = 4) thought the criteria would not be easy to use;
and 24.0% (n = 18) had no opinion. There were no differences between countries nor for the
level of specialization (Fisher’s exact tests, p> .05).
Of the HCPs, 45.9% (n = 34) thought that the duration (several months) was difficult to
determine, while 36.5% (n = 27) thought it was not difficult. The rest had no opinion (13.5%;
n = 10); or another response (4.1%; n = 3). The responses did not differ for the level of speciali-
zation nor between the countries (Fisher’s exact test> .05).
Of the healthcare providers, 40.5% (n = 30) thought it was possible to make a distinction
betweenmild GI and a situation in which the diagnosis is met; others thought this was not pos-
sible (18.9%; n = 14); did not know (27.0%; n = 20); or had no opinion (13.5%; n = 10). The
responses differed between countries (Fisher’s exact test, p< .01). In the UK, 55.0% (n = 11) of
the healthcare providers thought it was possible to make a distinction betweenmild GI and a
situation in which the diagnosis is met; 30.0% (n = 6) thought this was not possible; and 15.0%
(n = 3) had no opinion. No HCP selected “don’t know”. In the NL, 35.2% (n = 19) of the
healthcare providers thought it was possible to make a distinction betweenmild GI and a situa-
tion in which the diagnosis is met; 14.8% (n = 8) thought this was not possible; 13.0% (n = 7)
had no opinion; and 37.0% (n = 20) selected “don’t know”. There were no differences between
specialized and not specializedHCPs (χ2(3) = 5.28, p = .16).
Healthcare providers mostly thought that the removal of the distress criterion would not
make it more difficult to diagnose people (48.6%; n = 36); however others thought it would
becomemore difficult (31.1%; n = 23); and the rest did not know (10.8%; n = 8); or had no
opinion (9.5%; n = 7). There were no differences between countries or level of specialization.
Discussion
The main aim of this study was to collect the views of serviceusers of transgender healthcare and
other stakeholders (i.e., parents of trans children, and siblings or partners of trans people) and
healthcare providers regarding the proposed terminology and diagnostic criteria for Gender
Incongruence of adolescents and adults in the new edition of the ICD (ICD-11). The study found
that overall the proposed changes in the ICD-11 diagnosis of Gender Incongruence of Adoles-
cence and Adulthood were considered an improvement on the ICD-10 diagnosis of Transsexual-
ism. Though a variety of diagnostic terms were mentioned, UK respondents most often chose
gender incongruence as the preferred diagnostic term. The twomost preferred positions of the
GIAA diagnosis in ICD-11 were for it to be placed in a separate chapter dealing with Sexual- and
Gender-related Health, or as a Z-code. It should be noted that the name of the new chapter was
slightly different in the survey than in the original proposal of theWGSDSH, whose first prefer-
ence was for placement in a separate chapter focusedon gender incongruenceonly [3]. Their sec-
ond preference was for the GIAA to be placed in a new chapter focusing on sexual and gender
health [3]. In the current ICD beta version, the focus on gender is lost and reads: Conditions
related to SexualHealth, see [11]. The preference for placement differed by country;with the first
option being preferred by the Dutch and Flemish participants and the latter by the UK partici-
pants. This differencemay be explained by several factors. First, in the UK, the National Health-
care System (NHS) is funded through central taxation and provides a comprehensive range of
health services—thevast majority of which are free at the point of use for people legally resident
in the United Kingdom. It is not an insurance-based system and although ICD diagnoses are col-
lected, the funding is not dependedupon them; therefore diagnoseswhich are part of Z-code
may still be funded. In contrast, in the Netherlands treatments based on Z-codes are not reim-
bursed by insurance companies which wouldmake this a less desirable option in terms of service
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provision. Gender Incongruence as a Z-codemight compromise access to care for transgender
people, and therefore this placement option may be a less popular choice in the Netherlands than
in the UK, where access to care would be unaffected by this change in placement. Second, in the
UK, transgender participants more often report experiencingdiscrimination than in the Nether-
lands. Also, compared to Dutch participants, more UK participants think a GI diagnosis has a
stigmatizing effect. Therefore, the need for destigmatization (in this case through less stigmatiz-
ing Z-codes)might bemore relevant and stronger in the UK than in NL.
When the ICD-11 proposal was made available—and the survey created—this was based on
the assumption that a GIAA diagnosis was retained in ICD-11 and removal of the diagnosis
was not recommended because this “would undoubtedly prove to be a significant impediment
for transgender people seeking access to medical treatment” (p. 575, [3]). Therefore, questions
regarding the possibility of excluding the GIAA diagnosis in its entirety from ICD-11 were not
extensively explored in the survey. When asked in which chapter the GIAA diagnosis should
be placed in ICD-11, only a small number of participants stated that the GI diagnosis should
not be in the ICD at all. This response option was the eighth option out of nine and the ques-
tion does not necessarily imply that there would be a response option for not being in the ICD;
so some people might have chosen a category that they found acceptable and might not have
finished reading all the options. In other words, their responses might have been based on the
idea that if the diagnosis is retained, where should it be placed. The number of people that
favored removing the GI diagnosis thus might be higher than the percentage of respondents
that picked “It should not be in the ICD at all”.
The UK survey includedmore questions regarding exclusion of the GIAA diagnosis. The
findings on this issue, however, seem to contradict responses to other questions: on the one
hand, most UK transgender respondents thought there should be a diagnosis related to being
trans and thought there were benefits towards a diagnosis; on the other hand almost half of the
transgender respondents indicated they wanted to remove the diagnoses from the ICD in its
entirety if it were removed from the chapter on “psychiatric disorders” (healthcare providers
were split on this question; some wanted to retain the diagnosis, others preferred removal).
Also, when asked about the preferred chapter, only a small number of participants thought the
diagnosis should not be in the ICD at all.
As described above, the desire to destigmatize gender incongruence and the importance of
securing access to care has been describedas the central dilemma in both the DSM-5 and ICD-
11 revision processes [3]. This dilemma is clearly reflected in the results of this study. While
many participants thought a GI diagnosis has a stigmatizing effect,many also see benefits in
having an ICD-11 GIAA diagnosis. The contradicting findings in the UK survey regarding the
preference of retaining or removing the GIAA diagnosis (see above) reflects this dilemma.
Therefore, at one point in the survey the desire of a respondent to reduce stigmamight have
beenmore salient, whereas at other times the benefits of including a diagnosis (e.g., securing
access to reimbursed healthcare) may have beenmore so. It is worth noting that the surveywas
somewhat lengthy and so shifts in saliency of competing issues and/or desires are likely.
There were no large differences between the responses of the transgender participants and
the healthcare providers. Their responses reflected the same dilemmas as the responses of the
entire group. Healthcare providers were generally positive about the GIAA diagnosis and most
thought the diagnosis was clearly defined and easy to use in their practice/work. The main
point of critique of HCPs was aimed towards the duration requirement of “several months”.
Almost half of the HCPs thought the duration of “several months” was too short and difficult
to determine. Including more practical suggestions by theWHO in the ICD-11 on this matter
would be advisable. One such advice could be that a clinician should judge if the gender incon-
gruence is stable enough to permit treatment without mentioning a specific time-frame.
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Though this may be sufficiently practical for experiencedpractitioners, it may pose problems
for less experiencedpractitioners.
Some limitations were present in this study. First, the recruitment of the transgender partici-
pants started with individuals who intended to receive, are receiving, or have received gender
identity care (see Table A in S3 Text). Although this allows comparison between both coun-
tries, as it is a relatively homogenous group, it does not allow for the views of non-treatment
seeking trans people to be collected. Transgender people who do not want or needmedical or
psychological care [15] may have a different perspective on the GI diagnosis in the ICD-11;
and particularly in the matter of widening the scope of the diagnosis as they will then fulfill
diagnostic criteria under the new ICD. Transgender people who do not need/want treatment,
but do fulfill the diagnostic criteria, might be more opposed to including any GI diagnosis in
the ICD-11 than the group included in this study. For the latter, reimbursedmedical treatment
is only possible in the NL through a diagnostic code other than a Z-code and in the UK some
diagnosismust be made for treatment. Therefore, people who needmedical care clearly benefit
from the presence of a diagnosis as it makes them eligible for reimbursed healthcare. As a
result, they might be more positive and less worried about the possible stigmatizing effect of
including a GI diagnosis in ICD-11.
A second limitation was the fact that the surveywas long and involved some complex con-
cepts. As a result, the sample may have been biased towards participants with a higher level of
education, and those whomay have difficultiesunderstanding the surveymay have given up. In
addition, only those with strong opinions may have beenmotivated to complete the survey to the
end. This opens up the possibility that the numbers of potentially more ambivalent people are not
accounted for. In addition, no paper surveyswere completed which also indicated that only those
participants with access to the internet took part, whichmay exclude certain demographics.
In conclusion, it seems that respondents were overall in favor of the proposed changes
regarding the terminology and diagnostic category of Gender Incongruence of Adolescence
and Adulthood (GIAA), albeit with some caveats–especially that clear advice as to the duration
of the gender incongruence from theWHO is required. If a GIAA diagnosis is retained, it is
important that it is not-stigmatizing, and moving it away from the mental and behavioral chap-
ter will likely help with this. Those who oppose removing (or want to retain) a GIAA diagnosis
in ICD-11 seem to have a practical view that in some current health care systems, a diagnosis is
needed in order to access healthcare that is reimbursed—and so available to a wide variety of
people who require treatment.
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